The use of marker vaccines in eradication of herpesviruses

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 75-81

  Van Oirschot, J T ^a   Kaashoek, M J ^a   Rijsewijk, F A M ^a   Stegeman, J A ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Animal Health Service Boxtel   (Netherlands)

Author keywords

Bovine herpesvirus 1; Eradication; Marker vaccinc; Pseudorabies; Vaccine efficacy

Indexed keywords

ANTIBODIES; GENETIC ENGINEERING; IMMUNIZATION; VIRUSES;

BOVINE HERPESVIRUS; MARKER VACCINE; PSEUDORABIES; VACCINE EFFICACY; WILD TYPE VIRUS;

VACCINES;

HERPES SIMPLEX VACCINE; MARKER VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY RESPONSE; BOVINE HERPES VIRUS; CONFERENCE PAPER; HERPES VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; VACCINATION;

BOVINAE; BOVINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HERPESVIRUS 1; HERPETOVIRUS; SUID HERPESVIRUS 1;

EID: 0030042257     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00129-8     Document Type: Conference Paper

References (37)

1. Arias, M., Moyana, M., Escribano, J.M. and Sanchez-Vizcaino, J.M. (1992) Evaluation of two ELISA kits for the detection of Aujeszky's disease antibodies in pigs. Vet. Rec. 131, 391-393.
2. Cowen, P., Li, S., Erickson, G.A. and Blanchard, D. (1990) Reactivation of latent pseudorabies virus infection in vacci nated commercial sows. Am. J. Vet. Res. 51, 354-358.
3. De Jong, M.C.M. and Kimman, T.G. (1994) Experimental quan tification of vaccine-induced reduction in virus transmission. Vaccine 12, 761-766.
4. Flores, E.F., Osorio, F.A., Zanella, E.L., Kit, S. and Kit, M. (1993) Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest. 5, 534-540.
5. Gielkens, A.L.J., Van Oirschot, J.T. and Berns, A.J.M. (1985) Genome differences among field isolates and vaccine strains of pseudorabies virus. J. Gen. Virol. 66, 69-82.
6. Glazenburg, K.L., Moormann, R.J.M., Kimman, T.G., Gielkens, A.L.J. and Peeters, B.P.H. (1995) Genetic recombination of pseudorabies virus: evidence that homologous recombination between insert sequences is less frequent than between autologous sequences. Arch. Virol. 140, 671-685.
7. Halloran, M.E., Haber, M., Longini. Jr., I.M. and Struchiner, J. (1991) Direct and indirect effects in vaccine efficacy and vaccine effectiveness. Am. J. Epidemiol. 133, 323-331.
8. Kaashoek, M.J., Moerman, A., Madic, J., Rijsewijk, F.A.M., Quak, J., Gielkens, A.L.J. and van Oirschot, J.T. (1994) A conventionally-attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-444.
9. Kaashoek, M.J., Moerman, A., Madić, J.A., Weerdmeester, K., Maris-Veldhuis, M.A., Rijsewijk, F.A.M. and van Oirschot, J.T. (1995) An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13, 342-346.
10. Kimman, T.G. (1992) Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies. Vaccine 10, 363-365.
11. Kit, S., Otsuka, H. and Kit, M. (1990) Gene-deleted IBRV marker vaccine. Vet. Rec. 12, 363-364.
12. Kowalski, J., Gilbert, S.A., Van Drunen Littel-van den Hurk, S., Van den Hurk, J.V., Babiuk, L.A. and Zamb, T.J. (1993) Heat-shock promter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11, 1100-1108.
13. Mettenleiter, T.C., Lukacs, N. and Rziha, H.-J. (1985) Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol. 56, 307-311.
14. Moormann, R.J.M., De Rover, T., Briaire, J., Peeters, B.P.H., Gielkens, A.L.J. and Van Oirschot, J.T. (1990) Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen. Virol. 71, 1591-1595.
15. Quint, W.G.V., Gielkens, A.L.J., Berns, A.J.M., Van Oirschot, J.T. and Cuypers, H.T. (1987) Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines. J. Gen. Virol. 68, 523-534.
16. Schang, L.M., Kutish, G.F. and Osorio, F.A. (1994) Correlation between precolonization of trigeminal ganglia by attenuated strains of pseudorabies virus and resistance to wild-type virus latency. J. Virol. 68, 8470-8476.
17. Stegeman, J.A. (1995) Pseudorabies virus eradication by area-wide vaccination is feasible. PhD Thesis, Utrecht University, Utrecht, The Netherlands.
18. Stegeman, J.A., Kimman, T.G., Van Oirschot, J.T., Tielen, M.J.M. and Hunneman, W.A. (1994a) Spread of Aujeszky's disease virus within pig herds in an intensively vaccinated region. Vet. Rec. 134, 327-330.
19. Stegeman, J.A., Tielen, M.J.M., Kimman, T.G., Van Oirschot, J.T., Hunneman, W.A. and Berndsen, F.W. (1994b) Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections. Vaccine 12, 527-531.
20. Stegeman, J.A., Van Oirschot, J.T., Kimman, T.G., Tielen, M.J.M., Hunneman, W.A. and Berndsen, F.W. (1994c) Reduction of the prevalence of pseudorabies virus-infected breeding pigs by use of intensive regional vaccination. Am. J. Vet. Res. 55, 1381-1385.
21. Strube, W., Auer, S., Abar, B., Bergle, R.D., Block, W., Heinen, E., Kretzdorn, D., Rodenbach, C. and Schmeer, N. (1994a) Infectious bovine rhinotracheitis marker vaccines - chemically inactivated and live attenuated - for the improvement of BHV1 control programs: 1. Safety aspects in the vaccine development. Proc. XVIII World Buiatrics Congress, Bologna. pp. 757-760.
22. Strube, W., Auer, S., Abar, B., Bergle, R.D., Block, W., Heinen, E., Kretzdom, D., Rodenbach, C. and Schmeer, N. (1994b) Infectious bovine rhinotracheitis marker vaccines - chemically inactivated and live attenuated - for the improvement of BHV1 control programs: II. Evaluation of immunogenicty. Proc. XVIII World Buiatrics Congress, Bologna. pp. 761-764.
23. Van Drunen Littel-van den Hurk, S., Van Donkersgoed, J., Kowalski, J., Van den Hurk, J.V., Harland, R., Babiuk, L.A. and Zamb, T.J. (1994) A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12, 1295-1302.
24. Van Engelenburg, F.A.C., Kaashoek, M.J., Rijsewijk, F.A.M., Van den Burg, L., Moerman, A., Gielkens, A.L.J. and Van Oirschot, J.T. (1994) A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol. 75, 2311-2318.
25. Van Engelenburg, F.A.C., Kaashoek, M.J., Van Oirschot, J.T. and Rijsewijk, F.A.M. (1995) A glycoprolein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. J. Gen. Virol. 76, 2387-2392.
26. Vannier, P. and Carnero, R. (1985) Effects pour le porc d'un virus propagé par un vaccin contre la maladie d'Aujeszky. Le Point Vét. 17, 325-331.
27. Vannier, P., Hutet, E., Bourgueil, E. and Cariolet, R. (1991) Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vet. Microbiol. 29, 213-223.
28. Van Oirschot, J.T. (1987) Intranasal vaccination of pigs against Aujeszky's disease. Comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres. Res. Vet. Sci. 42, 12-16.
29. Van Oirschot, J.T. (1988) Induction of antibodies to glycoprotein I in (vaccinated) pigs exposed to different doses of a mild-virulent strain of Aujeszky's disease virus. Vet. Rec. 121, 599-603.
30. Van Oirschot, J.T. (1989) The antibody response to glycoprotein I and the control of Aujeszky's disease virus. In: Van Oirschot, J.T. (Ed.) CEC Seminar on 'Vaccination and Control of Aujeszky's disease virus'. Kluwer Academic Publishers, Dordrecht. pp. 129-138.
31. Van Oirschot, J.T. (1991) Intranasal vaccination of pigs against Aujeszky's disease: Protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies. Vet. Microbiol. 27, 103-113.
32. Van Oirschot, J.T. (1992) Properties of gI-negative vaccines and companion diagnostic tests for the eradication of Aujeszky's disease. Proc. 96th Annu. Meeting USA Anim. Health Assoc., Louisville, pp. 405-416.
33. Van Oirschot, J.T. and Gielkens, A.L.J. (1984) Intranasal vaccination of pigs against pseudorabies. Absence of vaccinal virus latency and failure to prevent latency of virulent virus. Am. J. Vet. Res. 45, 2099-2103.
34. Van Oirschot, J.T., Rziha, H.J., Moonen, P.J.L.M., Pol, J.M.A. and Van Zaane, D. (1986) Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67, 1179-1182.
35. Van Oirschot, J.T., Terpstra, C., Moormann, R.J.M., Berns, A.J.M. and Gielkens, A.L.J. (1990) Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I. Vet. Rec. 127, 443-446.
36. Van Oirschot, J.T., Daus, F., Kimman, T.G. and Van Zaane, D. (1991a) Antibody response to glycoprotein I in maternally immune pigs to a mildly virulent strain of pseudorabies virus. Am. J. Vet. Res. 52, 1788-1793.
37. Van Oirschot, J.T., Moormann, R.J.M., Berns, A.J.M. and Giekens, A.L.J. (1991b) Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I. Am. J. Vet. Res. 52, 1056-1060.